Aggregated China Business Blogs



China Pharma Continues to Outdo Itself

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
January 31, 2008|

China Pharma Holdings, Inc. (CPHI.OB) received SFDA approval for a generic version of Bumetanide injection, a diuretic that is given for a wide variety of indications, including hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Selling China Pharma on Market Turbulence
  • China Pharma: New Product Launches Should Make for a Great 2008
  • China Pharma Holdings' Choice of IR Firm Looks Promising
  • Hotel Continues 2007 Christmas Charity Drive In Shanghai
  • Wuxi Pharma: Too Much of a Good Thing

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |